{"transactions":[{"id":817253,"issuer":{"id":5935,"kind":"organization","name":"Turn Therapeutics Inc."},"owners":[{"id":53938,"kind":"person","name":"Chaudhary Zuraiz","position":1,"cik":"0002086494","reported_name":"Chaudhary Zuraiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee stock option (right to buy)","published_at":"2026-04-03T12:06:51.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as follows: 25% will vest on the first anniversary of the grant date, with the remaining 75% vesting ratably over the following 36 months, subject to the Reporting Person's continued employment and the terms and conditions of the applicable option award and the Issuer's 2025 Omnibus Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option will vest as follows: 25% will vest on the first anniversary of the grant date, with the remaining 75% vesting ratably over the following 36 months, subject to the Reporting Person's continued employment and the terms and conditions of the applicable option award and the Issuer's 2025 Omnibus Incentive Plan."}],"balance_after":80000,"derivative":{"exercise_price":3.12,"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001213900-26-039712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2086494/000121390026039712/ownership.xml","form_type":"4"}},{"id":971600,"issuer":{"id":5935,"kind":"organization","name":"Turn Therapeutics Inc."},"owners":[{"id":53938,"kind":"person","name":"Chaudhary Zuraiz","position":1,"cik":"0002086494","reported_name":"Chaudhary Zuraiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-12T23:00:02.000Z","date":"2025-12-12","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":3.5,"value":8750.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001213900-25-121326","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2086494/000121390025121326/ownership.xml","form_type":"4"}},{"id":991618,"issuer":{"id":5935,"kind":"organization","name":"Turn Therapeutics Inc."},"owners":[{"id":53938,"kind":"person","name":"Chaudhary Zuraiz","position":1,"cik":"0002086494","reported_name":"Chaudhary Zuraiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-21T22:43:52.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.29,"value":3290.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-25-113723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2086494/000121390025113723/ownership.xml","form_type":"4"}},{"id":991617,"issuer":{"id":5935,"kind":"organization","name":"Turn Therapeutics Inc."},"owners":[{"id":53938,"kind":"person","name":"Chaudhary Zuraiz","position":1,"cik":"0002086494","reported_name":"Chaudhary Zuraiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-21T22:43:52.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":1450,"price":2.61,"value":3784.5,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001213900-25-113723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2086494/000121390025113723/ownership.xml","form_type":"4"}},{"id":998092,"issuer":{"id":5935,"kind":"organization","name":"Turn Therapeutics Inc."},"owners":[{"id":53938,"kind":"person","name":"Chaudhary Zuraiz","position":1,"cik":"0002086494","reported_name":"Chaudhary Zuraiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-18T02:23:35.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":3.62,"value":9050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.50 to $3.69, inclusive. The Reporting Person undertakes to provide to Turn Therapeutics Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":7550,"source":{"system":"sec-edgar","filing":"0001213900-25-111713","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2086494/000121390025111713/ownership.xml","form_type":"4"}},{"id":1014308,"issuer":{"id":5935,"kind":"organization","name":"Turn Therapeutics Inc."},"owners":[{"id":53938,"kind":"person","name":"Chaudhary Zuraiz","position":1,"cik":"0002086494","reported_name":"Chaudhary Zuraiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-24T01:03:44.000Z","date":"2025-10-23","kind":"purchase","planned":false,"acquired":true,"shares":5050,"price":4.95,"value":24997.5,"ownership":{"direct":true},"balance_after":5050,"source":{"system":"sec-edgar","filing":"0001104659-25-101924","document":"tm2529397-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2086494/000110465925101924/tm2529397-2_4seq1.xml","form_type":"4"}},{"id":1020397,"issuer":{"id":5935,"kind":"organization","name":"Turn Therapeutics Inc."},"owners":[{"id":53938,"kind":"person","name":"Chaudhary Zuraiz","position":1,"cik":"0002086494","reported_name":"Chaudhary Zuraiz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee stock option (right to buy)","published_at":"2025-10-10T13:42:11.000Z","date":"2025-10-08","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects an award of stock options to purchase shares of the Issuer's common stock granted under the Company's 2025 Omnibus Incentive Plan. 25% of the options shall vest on May 1, 2026, and 6.25% of the options shall vest in equal quarterly installments thereafter, in each case, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":240000,"derivative":{"exercise_price":10,"expiration_date":"2035-10-07","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001104659-25-098569","document":"tm2528487-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2086494/000110465925098569/tm2528487-3_4seq1.xml","form_type":"4"}}]}